Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title	Grant Number	Program Official Sort descending
Maitra, Anirban	New York University School Of Medicine United States	Clinical Validation Center for Early Detection of Pancreatic Cancer	7U01CA200468-09	Matthew Young, Ph.D.
Cocucci, Emanuele	Ohio State University United States	A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL	5R01CA270251-04	Matthew Young, Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	5U01CA274514-03	Matthew Young, Ph.D.
Storz, Peter	Mayo Clinic Jacksonville United States	Deiminated molecules as markers for developing pancreatic cancer - A1	5R21CA279916-02	Matthew Young, Ph.D.
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	5R01CA272766-03	Matthew Young, Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-05	Matthew Young, Ph.D.
Hitchins, Megan P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	7R01CA252042-05	Matthew Young, Ph.D.
Zhu, Yazhen	University Of California Los Angeles United States	Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles	5R01CA277530-03	Matthew Young, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-04	Matthew Young, Ph.D.
Iyer, Prasad G.	Mayo Clinic Arizona United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	2R01CA241164-07	Matthew Young, Ph.D.
Balaj, Leonora	Massachusetts General Hospital United States	Standardized Molecular Analyses of Glioma EVs	5R01CA237500-05	Matthew Young, Ph.D.
Hur, Chin	Columbia University Health Sciences United States	Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype	3R01CA257333-05S1	Matthew Young, Ph.D.
Sen, Subrata	University Of Tx Md Anderson Can Ctr United States	Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer	5U01CA214263-07	Matthew Young, Ph.D.
Alambeigi, Farshid	University Of Texas At Austin United States	A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps	5R21CA280747-02	Matthew Young, Ph.D.
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-04	Matthew Young, Ph.D.